Australia - English - Department of Health (Therapeutic Goods Administration)

gc australasia dental pty ltd - ct1236 - clinical chemistry biological screening ivds - to be used by dental professionals chairside to test the quality, ph and buffering capacity of saliva.

Australia - English - Department of Health (Therapeutic Goods Administration)

carl zeiss pty ltd - 47240 - vitreoretinal tamponade tubing - this single use device is an accessory of carl zeiss phaco systems with posterior segment functionality. it has been designed to activate the plunger of a syringe preloaded with silicone oil, so as to allow the buffering procedures with fluids. this device is used during ophthalmic vitreoretinal surgery.

United States - English - NLM (National Library of Medicine)

west-ward pharmaceutical corp - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - metronidazole 500 mg in 100 ml - metronidazole injection, usp is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. indicated surgical procedures should be performed in conjunction with metronidazole injection, usp therapy. in a mixed aerobic and anaerobic infection, antibiotics appropriate for the treatment of the aerobic infection should be used in addition to metronidazole injection, usp. metronidazole injection, usp is effective in bacteroides fragilis infections resistant to clindamycin, chloramphenicol and penicillin. intra-abdominal infections , including peritonitis, intra-abdominal abscess and liver abscess, caused by bacteroides species including the b. fragilis group (b. fragilis, b. distasonis, b. ovatus, b. thetaiotaomicron, b. vulgatus ), clostridium species, eubacterium species, peptococcus species and peptostreptococcus species. skin and skin structure infections caused by bacteroides species including the b. fragilis group, clostridium species, peptococcus species, peptost

United States - English - NLM (National Library of Medicine)

gilmer industries, inc. - iodine (unii: 9679tc07x4) (iodine - unii:9679tc07x4), lactic acid (unii: 33x04xa5at) (lactic acid - unii:33x04xa5at) - iodine 2500 mg in 1 l - dual synergy for external use only on dairy cows warning! may cause eye irritation. may be harmful if swallowed. keep out of reach of children use on each teat as an aid in a complete cow health care program to help reduce the spread of organisms that may cause mastitis. not intended to cure or help the healing of chapped or irritated teats. in case of irritation or chapping, have cow examined by a veterinarian. active ingredients iodine ................................................................................ 0.25% lactic acid ......................................................................... 2.00% inactive ingredients emollient system, surfactant, and buffering agent............ 97.75% first aid eyes: immediately flush eyes with plenty of water for at least 15 minutes occasionally lifting the upper and lower lids. contact a physician immediately. ingestion: do not induce vomiting. drink large amounts of milk or water. contact a physician immediately. do not give anything by mouth to an unc

United States - English - NLM (National Library of Medicine)

cardinal health - sodium citrate, unspecified form (unii: 1q73q2julr) (anhydrous citric acid - unii:xf417d3psl), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - sodium citrate 500 mg in 5 ml - sodium citrate and citric acid oral solution usp is an effective alkalinizing agent. it is useful in those conditions where long-term maintenance of an alkaline urine is desirable, and is of value in the alleviation of chronic metabolic acidosis, such as results from chronic renal insufficiency or the syndrome of renal tubular acidosis, especially when the administration of potassium salts is undesirable or contraindicated. this product is also useful for buffering and neutralizing gastric hydrochloric acid quickly and effectively. sodium citrate and citric acid oral solution usp is concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary ph around the clock, usually without the necessity of a 2 a.m. dose. this product alkalinizes the urine without producing a systemic alkalosis in the recommended dosage. this product is highly palatable, pleasant tasting, and tolerable, even when administered for long periods. patients on sodium-restricted diets or with s

United States - English - NLM (National Library of Medicine)

atlantic biologicals corp. - sodium citrate (unii: 1q73q2julr) (anhydrous citric acid - unii:xf417d3psl), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - sodium citrate 500 mg in 5 ml - sodium citrate and citric acid oral solution usp is an effective alkalinizing agent. it is useful in those conditions where long-term maintenance of an alkaline urine is desirable, and is of value in the alleviation of chronic metabolic acidosis, such as results from chronic renal insufficiency or the syndrome of renal tubular acidosis, especially when the administration of potassium salts is undesirable or contraindicated. this product is also useful for buffering and neutralizing gastric hydrochloric acid quickly and effectively. sodium citrate and citric acid oral solution usp is concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary ph around the clock, usually without the necessity of a 2 a.m. dose. this product alkalinizes the urine without producing a systemic alkalosis in the recommended dosage. this product is highly palatable, pleasant tasting, and tolerable, even when administered for long periods. patients on sodium-restricted diets or with s

United States - English - NLM (National Library of Medicine)

pharmaceutical associates, inc. - sodium citrate (unii: 1q73q2julr) (anhydrous citric acid - unii:xf417d3psl), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - sodium citrate 500 mg in 5 ml - sodium citrate and citric acid oral solution usp is an effective alkalinizing agent. it is useful in those conditions where long-term maintenance of an alkaline urine is desirable, and is of value in the alleviation of chronic metabolic acidosis, such as results from chronic renal insufficiency or the syndrome of renal tubular acidosis, especially when the administration of potassium salts is undesirable or contraindicated. this product is also useful for buffering and neutralizing gastric hydrochloric acid quickly and effectively. sodium citrate and citric acid oral solution usp is concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary ph around the clock, usually without the necessity of a 2 a.m. dose. this product alkalinizes the urine without producing a systemic alkalosis in the recommended dosage. this product is highly palatable, pleasant tasting, and tolerable, even when administered for long periods. patients on sodium-restricted diets or with s

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

kenso corporation (m) sdn. bhd. - iprodione; liquid hydrocarbon - suspension concentrate - iprodione carbamate active 250.0 g/l; liquid hydrocarbon solvent other 332.0 g/l - fungicide

United States - English - NLM (National Library of Medicine)

cardinal health - sodium citrate, unspecified form (unii: 1q73q2julr) (anhydrous citric acid - unii:xf417d3psl), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - sodium citrate and citric acid oral solution usp is an effective alkalinizing agent. it is useful in those conditions where long-term maintenance of an alkaline urine is desirable, and is of value in the alleviation of chronic metabolic acidosis, such as results from chronic renal insufficiency or the syndrome of renal tubular acidosis, especially when the administration of potassium salts is undesirable or contraindicated. this product is also useful for buffering and neutralizing gastric hydrochloric acid quickly and effectively. sodium citrate and citric acid oral solution usp is concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary ph around the clock, usually without the necessity of a 2 a.m. dose. this product alkalinizes the urine without producing a systemic alkalosis in the recommended dosage. this product is highly palatable, pleasant tasting, and tolerable, even when administered for long periods. patients on sodium-restricted diets or with s

United States - English - NLM (National Library of Medicine)

activpower inc. - hyaluronate sodium (unii: yse9ppt4th) (hyaluronic acid - unii:s270n0trqy), dimethyl sulfone (unii: 9h4po4z4ft) (dimethyl sulfone - unii:9h4po4z4ft), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), creatine monohydrate (unii: 9603ln7r2q) (creatine - unii:mu72812gk0), new zealand green mussel (unii: 1l5332yq7u) (new zealand green mussel - unii:1l5332yq7u), holothuria sea cucumber (unii: 6zf4r28h4a) (holothuria sea cucumber - unii:6zf4r28h4a) - uses: this product is intended for intermittent or supplementary dosing along with a regular complete diet. best dosed during mealtime. note!!! add 1-4 cup water to powder to maximize buffering, absorption and hydration